维普期刊资源整合服务平台（V6.5）

50篇 您的检索式：作者名="Steelman SL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Assay of the follicle-stimulating hormone based on the augmentation with human chorionic gonadotrophin显示文摘	Steelman SL Pohley FM	1953	Endocrinology1953，53，6：	1
2	Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy显示文摘	Steelman LS Franklin RA Abrams SL	2011	Leukemia2011，25，7：	1
3	Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/ STAT pathways to leukemia显示文摘	Steelman LS Abrams SL Whelan J	2008	Leukemia2008，22，4：	1
4	Role of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging显示文摘	Steelman LS Chappell WH Abrams SL	2011	Aging (Albany NY)2011，3，3：	1
5	Contributions of the Raf/MEK/ERK,PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia显示文摘	Steelman LS Abrams SL Whelan J	2008	Leukemia2008，22，4：	1
6	Contributions of the Raf/MEK/ERK,PI3K/PTEN/Akt/mTOR and Jak/ STAT pathways to leukemia 显示文摘	Steelman LS Abrams SL Whelan JE	2008	Leukemia2008，22，4：	1
7	The chemistry,pharmacology and clinical pharmacology of diflunisal显示文摘	Cirillo VJ Tempero KF	1978	Curr Med Res Opin1978，5，：	1
8	Contributions of the Rafl MEKIERK, PI3K1PTENI AktimTOR and JakiSTAT pathways to leukemia 显示文摘	Steelman LS Abrams SL Whelan J	2008	Leukemia2008，22，4：	1
9	Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy显示文摘	Steelman LS Franklin RA Abrams SL	2011	Leukemia2011，25，7：	1
10	Emerging Raf In- hibitors显示文摘	McCubrey JA Steelman LS Abrams SL	2009	Exp Opin Emerging Drugs2009，14，4：	1
11	GSK-3 as potential target for therapeutic intervention in cancer显示文摘	Mccubrey JA Steelman LS Bertrand FE Davis NM Sokolosky M Abrams SL	2014	Oncotarget2014，5，10：	1
12	Roles of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy- implications for cancer and aging 显示文摘	Steelman IS Chappell WH Abram SL	2011	Aging2011，3，3：	1
13	Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/m TOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging显示文摘	Steelman LS Chappell WH Abrams SL	2011	Aging(Albany NY)2011，3，3：	1
14	Emerging Raf Inhibitors显示文摘	McCubrey JA Steelman LS Abrams SL	2009	Expert Opin Emerg Drugs2009，14，4：	1
15	Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 显示文摘	Steelman LS Chappell WH Abrams SL	2011	Aging (Albany NY)2011，3，3：	1
16	Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK,PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy显示文摘	McCubrey JA Steelman LS Abrams SL		0，，：	1
17	Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 显示文摘	Steelman LS Chappell WH Abrams SL	2011	Aging (Albany NY)2011，3，3：	1
18	Assay of the follicle-stimulating hormone based on the augmentation with human chorionic gonadotrophin显示文摘	Steelman SL Poblcy FM	1953	Endocrinology1953，53，6：	1
19	The Raf/ MEK/ERK pathway can govern drug resistance,apopto-sis and sensitivity to targeted therapy显示文摘	Abrams SL Steelman LS Shelton JG	2010	Cell Cycle2010，9，9：	1
20	Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathway in malignant transformation and drug resistance 显示文摘	McCubrey JA Steelman LS Abrams SL	2006	Adv Enzyme Regul2006，46，18：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示